Department of Anesthesiology, Hebei General Hospital, Shijiazhuang, Hebei 050051, China.
Chin Med J (Engl). 2010 Jan 5;123(1):68-73.
Proteins or peptides can be directly transferred into cells when covalently linked to protein transduction domains (PTDs). TAT is one of the most widely studied PTDs. The effect of fusion protein TAT and heme oxygenase-1 (HO-1) on liver sinusoidal endothelial cells (SECs) apoptosis during cold storage is unknown. The present study aimed to determine whether fusion protein TAT-HO-1 would transduce efficiently into liver during cold storage, and, if so, to determine whether TAT-HO-1 would attenuate SECs apoptosis during preservation injury in rat.
Livers of Sprague-Dawley rats were harvested and randomly assigned to group 1 (HTK solution) and group 2 (HTK solution containing TAT-HO-1 fusion protein) according to the type of the preservation solution. The transduction efficiency of TAT-HO-1 was examined and the impairment of SECs was assessed during the period of cold storage followed by 1 hour of reperfusion.
TAT-HO-1 can transduce efficiently into liver during cold storage. A significantly lower apoptotic index of SECs was observed in group 2, at 6, 12 and 18 hours of cold storage after 1 hour reperfusion, when compared with group 1. TAT-HO-1 reduced HA and ET levels in liver at each time point. Both Bcl-2 and Bax protein were expressed in hepatocytes and SECs at the periphery of the sinusoidal space. Moreover, higher Bcl-2 expression and lower Bax expression were observed in group 2.
TAT-HO-1 can transduce efficiently into rat livers and shows a protective effect on SECs by attenuating apoptosis during cold ischemia/reperfusion injury. Protein transduction will be a novel therapeutic strategy to reduce the risk of preservation injury in liver transplantation.
当蛋白质或肽与蛋白转导结构域(PTD)共价连接时,可以直接将其转入细胞。TAT 是研究最多的 PTD 之一。融合蛋白 TAT 和血红素加氧酶-1(HO-1)在冷保存期间对肝窦内皮细胞(SEC)凋亡的影响尚不清楚。本研究旨在确定融合蛋白 TAT-HO-1 是否能在冷保存期间有效地转导到肝脏,并且,如果是这样,确定 TAT-HO-1 是否能减轻大鼠保存损伤期间 SEC 凋亡。
根据保存液的类型,将 Sprague-Dawley 大鼠的肝脏随机分为 1 组(HTK 溶液)和 2 组(HTK 溶液含 TAT-HO-1 融合蛋白)。在冷保存后 1 小时再灌注期间,检查 TAT-HO-1 的转导效率,并评估 SEC 的损伤。
TAT-HO-1 可在冷保存期间有效转导到肝脏。与 1 组相比,在再灌注后 6、12 和 18 小时冷保存时,2 组 SEC 的凋亡指数明显降低。TAT-HO-1 降低了肝组织在每个时间点的 HA 和 ET 水平。Bcl-2 和 Bax 蛋白均在肝实质细胞和窦周间隙周边的 SEC 中表达。此外,在 2 组中观察到更高的 Bcl-2 表达和更低的 Bax 表达。
TAT-HO-1 可有效转导到大鼠肝脏,并通过减轻冷缺血/再灌注损伤期间的细胞凋亡对 SEC 发挥保护作用。蛋白转导将成为减少肝移植保存损伤风险的一种新的治疗策略。